WFG Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
SGA
WFG Advisors's NVO Position: Q2 2017 in Review
WFG Advisors reduced its Novo Nordisk (NVO) stake by 99% in Q2 2017, selling an estimated $15.2K and leaving 4 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1629.
WFG Advisors first reported a position in NVO in Q2 2013 and has held it in 17 quarters since. The position peaked at $645K in Q3 2014. 484 funds tracked by Wall St. Rank hold NVO as of Q2 2017.
- WFG Advisors held 4 shares of Novo Nordisk worth $0 as of Q2 2017.
- WFG Advisors sold 754 Novo Nordisk shares in Q2 2017, an estimated $15.2K.
- Novo Nordisk made up ﹤0.01% of WFG Advisors's portfolio in Q2 2017, its #1629 holding.
- WFG Advisors first reported a position in Novo Nordisk in Q2 2013 and has held it in 17 quarters since.
- WFG Advisors's Novo Nordisk position peaked at $645K in Q3 2014.
- 484 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2017.
Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.